Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Vienna - Delayed Quote EUR

Banca Mediolanum S.p.A. (BMED.VI)

Compare
13.63
+0.07
+(0.52%)
As of 3:30:43 PM GMT+1. Market Open.
Loading Chart for BMED.VI
DELL
  • Previous Close 13.56
  • Open 13.56
  • Bid 13.51 x --
  • Ask 13.63 x --
  • Day's Range 13.56 - 13.63
  • 52 Week Range 9.60 - 13.97
  • Volume 0
  • Avg. Volume 43
  • Market Cap (intraday) 10.051B
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) 8.97
  • EPS (TTM) 1.52
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.74 (5.46%)
  • Ex-Dividend Date Nov 18, 2024
  • 1y Target Est --

Banca Mediolanum S.p.A. provides various banking products and services in Italy. The company offers current accounts; deposits; and mortgages and loans. It also provides debit, credit, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, other investments, trading, and retirement products; and life insurance products and services. In addition, the company engages in audio and television production business; real estate business; mutual fund and trust management business; and the provision of damage insurance, financial intermediation, and payment services. Banca Mediolanum S.p.A. founded in 1982 and is headquartered in Basiglio, Italy.

www.bancamediolanum.it

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BMED.VI

View More

Performance Overview: BMED.VI

Trailing total returns as of 2/25/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

BMED.VI
18.62%
FTSE MIB Index
13.52%

1-Year Return

BMED.VI
50.13%
FTSE MIB Index
18.67%

3-Year Return

BMED.VI
114.41%
FTSE MIB Index
50.57%

5-Year Return

BMED.VI
133.88%
FTSE MIB Index
68.07%

Compare To: BMED.VI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMED.VI

View More

Valuation Measures

As of 2/24/2025
  • Market Cap

    9.98B

  • Enterprise Value

    --

  • Trailing P/E

    8.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.93

  • Price/Book (mrq)

    2.48

  • Enterprise Value/Revenue

    5.07

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    56.18%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    30.53%

  • Revenue (ttm)

    1.99B

  • Net Income Avi to Common (ttm)

    1.12B

  • Diluted EPS (ttm)

    1.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.05B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BMED.VI

View More

People Also Watch